Translational Notes: Mess with Texas

Table 1. CPRIT's commercial portfolio. The Cancer Prevention & Research Institute of Texas (CPRIT) has issued about $760 million in funding to academic researchers, community health organizations and 11 companies in the state of Texas. Listed below are the company grants.

Recipient

Program

Funding ($M)

Cell Medica Ltd.

Company relocation and recruitment

15.6

Caliber Biotherapeutics LLC

Biobetter cancer mAbs

12.8

Peloton Therapeutics Inc.

Company formation, recruitment and relocation

11.0

Molecular Templates Inc.

Engineered Toxin Bodies (ETBs) as cancer therapeutics

10.6

Mirna Therapeutics Inc.

Cancer treatment including drug discovery, development and clinical trials

10.3

Kalon Biotherapeutics LLC

Formation of the Texas Cancer Therapeutics Process Development Lab

7.9

Pulmotect Inc.

Expanding the market and success rates for myeloablative cancer treatments using PUL-042,
an innate immune stimulant

7.1

Asuragen Inc.

Mutation profiling for cancer personalized medicine using next-generation sequencing

6.8

Bellicum Pharmaceuticals Inc.

Clinical development of CaspaCIDe cell therapy

5.7

Apollo Endosurgery Inc.

Medical devices to treat cancerous lesions in the gastrointestinal tract

5.0

Rules-Based Medicine Inc.

Cancer biology and genetics research using genomics and proteomics

3.0